Recognition of fish pain capacity has driven advances in pain management protocols for farmed fish, including analgesic use during painful procedures and welfare-based husbandry adjustments.
The evidence base for fish pain capacity has grown substantially over the past two decades, transforming from academic controversy to regulatory consideration in several jurisdictions. Fish subjected to painful procedures without analgesia show cortisol elevations, behavioral changes, and immune suppression consistent with pain responses in other vertebrates. The pharmaceutical tools for fish pain management exist; the barrier is regulatory frameworks and industry norms rather than technical feasibility. Progressive aquaculture operations are developing species-specific analgesic protocols as part of comprehensive welfare programs.